RecruitingPhase 4NCT04207931

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Sponsor

Wake Forest University Health Sciences

Enrollment

250 participants

Start Date

Apr 30, 2018

Study Type

INTERVENTIONAL

Conditions

Central Centrifugal Cicatricial Alopecia (CCCA)

Summary

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Doxycyline, a drug called Minoxidil, and others for people with central centrifugal cicatricial alopecia (ccca). The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTopical steroid class I-II

applied once daily - 18 month duration of the study

DRUGTriamcinolone Acetonide

Intralesional Steroid Injection, 7.5mg/cc. max dose of 3 cc. Scalp injections will be administered every 6-8 weeks, for a total of 8 injections.

DRUGDoxycyline

oral antibiotic twice daily for 6 months

DRUGMinoxidil

5% solution or foam started after month 8

Locations(1)

Wake Forest Baptist Health Department of Dermatology

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04207931